Evidence map›Paper›PMID 16455913›Full record

ArticleJournal of clinical microbiology2006

Use of electrochemical DNA biosensors for rapid molecular identification of uropathogens in clinical urine specimens.

Joseph C Liao, Mitra Mastali, Vincent Gau, Marc A Suchard, Annette K Møller, David A Bruckner, Jane T Babbitt, Yang Li, Jeffrey Gornbein, Elliot M Landaw and 3 more

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 209 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Integration of FISH and Microfluidics.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Joseph C LiaoDivision of Infectious Diseases, 111F, VA Greater LA Healthcare, Los Angeles, CA 90073, USA.
Mitra Mastali
Vincent Gau
Marc A Suchard
Annette K Møller
David A Bruckner
Jane T Babbitt
Yang Li
Jeffrey Gornbein
Elliot M Landaw
Edward R B McCabe
Bernard M Churchill
David A Haake
GeneFluidics (United States) · USInstitute of Human Genetics · PLUniversity of California, Los Angeles · USVA Greater Los Angeles Healthcare System · US

Funding

Uropathogen Detection Using DNA BiosensorsR01EB000127 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHURCHILL, BERNARD M · 2002 to 2006
$7.4M
NIBIB NIH HHS EB00127NIBIB NIH HHS R01 EB000127
6 · The paper itself

Abstract

We describe the first species-specific detection of bacterial pathogens in human clinical fluid samples using a microfabricated electrochemical sensor array. Each of the 16 sensors in the array consisted of three single-layer gold electrodes-working, reference, and auxiliary. Each of the working electrodes contained one representative from a library of capture probes, each specific for a clinically relevant bacterial urinary pathogen. The library included probes for Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Enterocococcus spp., and the Klebsiella-Enterobacter group. A bacterial 16S rRNA target derived from single-step bacterial lysis was hybridized both to the biotin-modified capture probe on the sensor surface and to a second, fluorescein-modified detector probe. Detection of the target-probe hybrids was achieved through binding of a horseradish peroxidase (HRP)-conjugated anti-fluorescein antibody to the detector probe. Amperometric measurement of the catalyzed HRP reaction was obtained at a fixed potential of -200 mV between the working and reference electrodes. Species-specific detection of as few as 2,600 uropathogenic bacteria in culture, inoculated urine, and clinical urine samples was achieved within 45 min from the beginning of sample processing. In a feasibility study of this amperometric detection system using blinded clinical urine specimens, the sensor array had 100% sensitivity for direct detection of gram-negative bacteria without nucleic acid purification or amplification. Identification was demonstrated for 98% of gram-negative bacteria for which species-specific probes were available. When combined with a microfluidics-based sample preparation module, the integrated system could serve as a point-of-care device for rapid diagnosis of urinary tract infections.

Indexed as

Biosensing TechniquesDNA, BacterialElectrochemistryGram-Negative BacteriaGram-Negative Bacterial InfectionsHumansSpecies SpecificityUrinary Tract InfectionsUrineDNA, Bacterial

Identifiers

PMID16455913
PMCPMC1392664
OpenAlexW2125434152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.